A million Omicron flu deaths in China this winter = "normal flu season"? - Paxlovid on sale in China - at 427 bucks a box (v 10 bucks in the US?)
For context, China has around 1.4 billion people - if a “normal” flu season claims 0.1% of the population that works out at 1.4 million people.
From here:
China’s Covid outbreak could kill a million: study – Asia Times
“A new study by researchers at the University of Hong Kong, who traveled to Beijing in November, estimated that 684 people per million would die in China’s reopening as many people have not received a booster shot. The researchers said if China had delayed the reopening to January 2023 and boosted its vaccination rates, the number of deaths could fall by 26%.”
“The report was not released publicly but was obtained and reviewed by Bloomberg, which estimated about 964,400 people could die from the coronavirus in China.”
The team also suggested that the fast growth of infections in China could lead to mutations of the virus.”
“On Monday, Li Ang, a spokesperson of the Beijing Municipal Health Commission, said the number of people who sought medical treatment at fever clinics in the capital city was 22,000 on December 11, about 16 times higher than the level a week earlier.
Li said about 19,000 people were found to have seasonal flu symptoms in the week ended December 11, about six times higher than the level recorded the previous week.”
“The National Health Commission announced that a total of 6,197 new Covid cases were recorded on Monday, down from 8,838 on Sunday. On Tuesday, the number dropped to 2,291 as all asymptomatic cases were excluded.”
Maybe Paxlovid will come to the rescue. From here:
China health app starts online sales of Pfizer's Paxlovid for COVID treatment (marketscreener.com)
“BEIJING (Reuters) -A Chinese healthcare platform has started selling Pfizer's oral COVID treatment pill Paxlovid in what appears to be the first retail sale of the drug in the country, as China braces for a surge in COVID patients.
Healthcare company 111.inc has started selling Paxlovid for 2,980 yuan ($426.80) per box, the sales page on the app showed on Tuesday.
People can purchase the medication on the app if they submit a positive COVID-19 test result. Chinese media Yicai reported in March that Paxlovid, which was approved by China in February, has been used to treat high-risk patients in hospitals in at least eight provinces.”
Here’s a snap of the box posted in the article. Sure looks like a box of 30? Mind you, it is Reuters reporting so it’s probably a stock photo.
($1 = 6.9822 Chinese yuan renminbi)
In the US a box of 30 goes for 10 bucks.
Paxlovid Prices, Coupons, Copay & Patient Assistance - Drugs.com
“Cases” are fraudulent, propaganda, meaningless, junk science. The casedemic is an instrument of totalitarian control.
SARS-CoV-2 PCR tests are scientifically meaningless. Kary Mullis himself, the inventor of Polymerase Chain Reaction (PCR) technology, regarded the PCR test as inappropriate to detect a viral infection. Gene sequence amplification does not indicate the presence of the SARS-CoV-2 virus.
https://bpa-pathology.com/covid19-pcr-tests-are-scientifically-meaningless/
Here’s what I don’t understand. When omicron was detected in South Africa they said omicron had no lower respiratory symptoms and there was no increase in hospitalisations due to this. They even declared the pandemic over and said it was no worse than the common cold. Then other countries were saying they found the same. No respiratory symptoms and no increase in hospitalisations from omicron. Ireland was one. But then suddenly the narrative changed and we were being told that omicron does lead to hospitalisation. The South African dr involved in discovering omicron has even said they were approached by western govts and the WHO with requests they stop telling people it had no lower respiratory symptoms and was mild. So is omicron really leading to hospitalisation when initially it didn’t? What’s going on?